Healthia Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Healthia.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 24.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Healthia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 253 | 5 | 15 | 23 | N/A |
| 3/31/2023 | 242 | 3 | 14 | 20 | N/A |
| 12/31/2022 | 232 | 1 | 12 | 18 | N/A |
| 9/30/2022 | 216 | -1 | 13 | 18 | N/A |
| 6/30/2022 | 200 | -3 | 14 | 17 | N/A |
| 3/31/2022 | 184 | -2 | 13 | 16 | N/A |
| 12/31/2021 | 168 | 0 | 12 | 15 | N/A |
| 9/30/2021 | 152 | 3 | 18 | 21 | N/A |
| 6/30/2021 | 137 | 5 | 23 | 26 | N/A |
| 3/31/2021 | 121 | 6 | 26 | 28 | N/A |
| 12/31/2020 | 105 | 7 | 29 | 31 | N/A |
| 9/30/2020 | 96 | 5 | 22 | 24 | N/A |
| 6/30/2020 | 87 | 3 | 16 | 17 | N/A |
| 3/31/2020 | 83 | 1 | 9 | 10 | N/A |
| 12/31/2019 | 79 | 0 | 2 | 3 | N/A |
| 9/30/2019 | 72 | 0 | -1 | 1 | N/A |
| 6/30/2019 | 65 | -1 | -4 | -2 | N/A |
| 3/31/2019 | 57 | -2 | -3 | 0 | N/A |
| 12/31/2018 | 48 | -3 | -1 | 2 | N/A |
| 9/30/2018 | 41 | -2 | -1 | 1 | N/A |
| 6/30/2018 | 34 | -2 | 0 | 1 | N/A |
| 6/30/2017 | 67 | 4 | N/A | N/A | N/A |
| 6/30/2016 | 67 | 4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HLA's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if HLA's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if HLA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if HLA's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if HLA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HLA's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/04 17:18 |
| End of Day Share Price | 2023/11/30 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healthia Limited is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Warren Jeffries | Canaccord Genuity |
| Wilson Wong | Jarden Limited |